Markus Fally , Jan Hansel , Rebecca C. Robey , Faiuna Haseeb , Ahmed Kouta , Thomas Williams , Timothy Felton , Alexander G. Mathioudakis
{"title":"Decoding community-acquired pneumonia: a systematic review and analysis of diagnostic criteria and definitions used in clinical trials","authors":"Markus Fally , Jan Hansel , Rebecca C. Robey , Faiuna Haseeb , Ahmed Kouta , Thomas Williams , Timothy Felton , Alexander G. Mathioudakis","doi":"10.1016/j.cmi.2024.12.028","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Community-acquired pneumonia (CAP) is a frequent and potentially life-threatening condition. Even though the disease is common, evidence on CAP management is often of variable quality. This may be reinforced by the lack of a systematic and homogeneous way of defining the disease in randomized controlled trials (RCTs).</div></div><div><h3>Objectives</h3><div>This study aims to assess the diagnostic criteria and definitions of the term ‘community-acquired’ used in RCTs on CAP management.</div></div><div><h3>Data sources</h3><div>On the basis of the protocol (PROSPERO 2019 CRD42019147411), we conducted a systematic search of Medline/PubMed and the Cochrane Register of Controlled Trials for RCTs published or registered between 2010 and 2024.</div></div><div><h3>Study eligibility criteria</h3><div>Study eligibility criteria included completed and ongoing RCTs.</div></div><div><h3>Participants</h3><div>Participants included adults hospitalized with CAP.</div></div><div><h3>Methods of data synthesis</h3><div>Data were collected using a tested extraction sheet, as endorsed by the Cochrane Collaboration. After cross-checking, data were synthesized in a narrative and tabular form.</div></div><div><h3>Results</h3><div>In total, 7173 records were identified through our searches. After removing records that did not fulfil the eligibility criteria, 170 studies were included. Diagnostic criteria were provided in 69.4% of studies, and the term ‘community-acquired’ was defined in 55.3% of studies. The most frequently included diagnostic criteria were pulmonary infiltrates (94.1%), cough (78.8%), fever (77.1%), dyspnoea (62.7%), sputum (57.6%), auscultation/percussion abnormalities (55.9%), and chest pain/discomfort (52.5%). The different criteria were used in 87 different sets across the studies. The term ‘community-acquired’ was defined in 57 different ways.</div></div><div><h3>Conclusions</h3><div>The diagnostic criteria and definitions of CAP in RCTs exhibit significant heterogeneity. Standardizing these criteria in clinical trials is crucial to ensure comparability across studies.</div></div>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":"31 5","pages":"Pages 724-730"},"PeriodicalIF":8.5000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1198743X24006165","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Community-acquired pneumonia (CAP) is a frequent and potentially life-threatening condition. Even though the disease is common, evidence on CAP management is often of variable quality. This may be reinforced by the lack of a systematic and homogeneous way of defining the disease in randomized controlled trials (RCTs).
Objectives
This study aims to assess the diagnostic criteria and definitions of the term ‘community-acquired’ used in RCTs on CAP management.
Data sources
On the basis of the protocol (PROSPERO 2019 CRD42019147411), we conducted a systematic search of Medline/PubMed and the Cochrane Register of Controlled Trials for RCTs published or registered between 2010 and 2024.
Study eligibility criteria
Study eligibility criteria included completed and ongoing RCTs.
Participants
Participants included adults hospitalized with CAP.
Methods of data synthesis
Data were collected using a tested extraction sheet, as endorsed by the Cochrane Collaboration. After cross-checking, data were synthesized in a narrative and tabular form.
Results
In total, 7173 records were identified through our searches. After removing records that did not fulfil the eligibility criteria, 170 studies were included. Diagnostic criteria were provided in 69.4% of studies, and the term ‘community-acquired’ was defined in 55.3% of studies. The most frequently included diagnostic criteria were pulmonary infiltrates (94.1%), cough (78.8%), fever (77.1%), dyspnoea (62.7%), sputum (57.6%), auscultation/percussion abnormalities (55.9%), and chest pain/discomfort (52.5%). The different criteria were used in 87 different sets across the studies. The term ‘community-acquired’ was defined in 57 different ways.
Conclusions
The diagnostic criteria and definitions of CAP in RCTs exhibit significant heterogeneity. Standardizing these criteria in clinical trials is crucial to ensure comparability across studies.
期刊介绍:
Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.